Results 241 to 250 of about 37,265 (258)

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Lancet, The, 2014
Philip C Buttery, Philippe Le Corvoisier, David P Breen   +2 more
exaly  

Ultrafast vector imaging of plasmonic skyrmion dynamics with deep subwavelength resolution

Science, 2020
Timothy Davis, David Janoschka, Pascal Dreher   +2 more
exaly  

Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

Science, 2009
Kejin Hu, Shulan Tian, Igor I Slukvin
exaly  

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2017
Qiang Guo, Zhe Zhang, Wei Chen
exaly  

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

Lancet, The, 2004
Kimberly C Gilmour, Christof von Kalle, Torben Barington   +2 more
exaly  

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

Lancet, The, 2015
Pei Liu, Wei Chen
exaly  

Improved reference genome of Aedes aegypti informs arbovirus vector control

Nature, 2018
Benjamin J Matthews, Olga Dudchenko, Sarah B Kingan   +2 more
exaly  

Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

Science, 2009
Nathalie Cartier, Nizar Mahlaoui, Céline Bellesme   +2 more
exaly  

Dengue: a continuing global threat

Nature Reviews Microbiology, 2010
Scott B Halstead, Philippe Buchy
exaly  

Layer thickness dependence of the current-induced effective field vector in Ta|CoFeB|MgO

Nature Materials, 2012
Junyeon Kim, Jaivardhan Sinha, Masamitsu Hayashi   +2 more
exaly